Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.

REACH

Guanidine, N-phenyl-, compd. with carbonic acid, hydrate (2:1:2)

EC number: 485-350-6 | CAS number: 405095-33-2

Life Cycle description
Uses advised against

Toxicological information

Endpoint summary

Administrative data

Description of key information

The following LD50 was determined for CA 1139 A:

LD50 in male rats: > 2000 mg/kg body weight

LD50 in female rats: > 1000, approx. 2000 mg/kg body weight

LD50 in rats of both sexes: > 2000 mg/kg body weight

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records

Reference

Endpoint:

acute toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Study period:

June - September 1992

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

guideline study with acceptable restrictions

Qualifier:

according to guideline

Guideline:

OECD Guideline 401 (Acute Oral Toxicity)

Deviations:

GLP compliance:

yes

Remarks:

This study has been performed in compliance with GLP in Switzerland, Procedures and Principles, March 1986, issued by the Swiss federal Department of the Interior and the Intercantonal Office for the Control of Medicaments.

Test type:

standard acute method

Limit test:

yes

Species:

rat

Strain:

other: Tif: RAI f (SPF)

Sex:

male/female

Route of administration:

oral: gavage

Vehicle:

other: 0.5% (w/v) carboxymethylcellulose in 0.1% (w/v) aqueous polysorbate 80

Doses:

1000 mg/kg, males and females
2000 mg/kg, males and females

No. of animals per sex per dose:

5 animals per sex per dose (total number of animals: 20)

Control animals:

Sex:

male

Dose descriptor:

LD50

Effect level:

> 2 000 mg/kg bw

Sex:

female

Dose descriptor:

LD50

Effect level:

> 1 000 mg/kg bw

Remarks on result:

other: approx. 2000 mg/kg bw

Key result

Sex:

male/female

Dose descriptor:

LD50

Effect level:

> 2 000 mg/kg bw

In-life observations

Animal No.

Observations

Admin. day

Days after administration

1000 mg/kg, males

1-5

Piloerection

1-5

Hunched post

1-5

Dyspnea

1-5

red. locom. act

1000 mg/kg, females

1, 3-5

Piloerection

1, 3-5

Hunched post

1, 3-5

Dyspnea

1, 3-5

red. locom. act

1, 3-5

tremor

1-5

ataxia

2000 mg/kg, males

1-4

Piloerection

1-4

Hunched post

1-4

Dyspnea

1-5

red. locom. act

2000 mg/kg, females

1,2,5

Piloerection

1,2,5

Hunched post

1,2,5

Dyspnea

1-5

red. locom. act

Tonic spasm

+ = slight; ++ = moderate, +++ = severe

hunched post = hunched posture

red. locom. act. = reduced locomotor activity

Interpretation of results:

GHS criteria not met

Conclusions:

LD50 in male rats: > 2000 mg/kg body weight
LD50 in female rats: > 1000, approx. 2000 mg/kg body weight
LD50 in rats of both sexes: > 2000 mg/kg body weight

Executive summary:

In an acute oral toxicity study (performed according to the OECD guideline 401), groups of young adult albino rats (Tif: RAI f (SPF)) of both sexes were given a single oral dose by gastric intubation of CA 1139 A in 0.5% (w/v) carboxymethylcellulose (in 0.1% (w/v) aqueous polysorbate 80) at doses of 1000 and 2000 mg/kg bw and observed for 14 days.

The following LD50 was determined for CA 1139 A:

LD50 in male rats: > 2000 mg/kg body weight

LD50 in female rats: > 1000, approx. 2000 mg/kg body weight

LD50 in rats of both sexes: > 2000 mg/kg body weight

Piloerection, hunched posture, and dyspnea were seen, being common symptoms in acute tests. Additionally, reduced locomotor activity was observed in all animals. In the females dosed 1000 mg/kg tremor, ataxia and respiratory sounds were noticed. In one female dosed with 2000 mg/kg tonic spasms were observed.

One female dosed with 1000 and one male and two females dosed with 2000 mg/kg died spontaneously within two days after administration.

The animals recovered within 4 to 7 days.

At necropsy, a spotted thymus was found in one female dosed with 2000 mg/kg. No deviations from normal morphology were found in the remaining animals.

Endpoint conclusion

Endpoint conclusion:: no adverse effect observed
Dose descriptor:: LD50
Value:: 2 000 mg/kg bw

Additional information

Justification for classification or non-classification

In a Guideline study according to OECD 401 no death animals were found with:

The following LD50 was determined for CA 1139 A:

LD50 in male rats: > 2000 mg/kg body weight

LD50 in female rats: > 1000, approx. 2000 mg/kg body weight

LD50 in rats of both sexes: > 2000 mg/kg body weight

Therefore no classification for acute toxicity is necessary.

Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.